Thiacalix[4]arene as molecular platform for design of alkaline phosphatase inhibitors

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 66, Issue 3, 2010, Pages 271-277

  Vovk, A I ^a   Kononets, L A ^a   Tanchuk, V Yu ^a   Drapailo, A B ^b   Kalchenko, V I ^b   Kukhar, V P ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY AND PETROCHEMISTRY   (Ukraine)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Ukraine)

Author keywords

Alkaline phosphatase; Calix 4 arene; Inhibition; Molecular docking; Phosphonic acid; Thiacalix 4 arene

Indexed keywords

EID: 77952292132     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-009-9607-9     Document Type: Article

References (31)

1. Engel, R.: Phosphonates as analogues of natural phosphates. Chem. Rev. 77, 349-367 (1977).
2. Hilderbrand, R. L.: The Role of Phosphonates in Living Systems. Boca Raton FL, CRC Press (1983).
3. Kukhar, V. P., Hudson, H. R. (eds.): Aminophosphonic and aminophosphinic acids: chemistry and biological activity. Wiley, LTD Inc., Chichester, UK (2000).
4. Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Monkkonen, J., Frith, J. C.: Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88, 2961-2978 (2000).
5. Bergstrom, J. D., Bostedor, R. G., Masarachia, P. J., Reszka, A. A., Rodan, G.: Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch. Biochem. Biophys. 373, 231-241 (2000).
6. Bukowski, J. F., Dascher, C. C., Das, H.: Alternative bisphosphonate targets and mechanisms of action. Biochem. Biophys. Res. Commun. 328, 746-750 (2005).
7. Vovk, A. I., Kalchenko, V. I., Cherenok, S. A., Kukhar, V. P., Muzychka, O. V., Lozynsky, M. O.: Calix[4]arene methylenebisphosphonic acids as calf intestine alkaline phosphatase inhibitors. Org. Biomol. Chem. 2, 3162-3166 (2004).
8. Cherenok, S., Vovk, A., Muravyova, I., Shivanyuk, A., Kukhar, V., Lipkowski, J., Kalchenko, V.: Calix[4]arene α-aminophosphonic acids: asymmetric synthesis and enantioselective inhibition of an alkaline phosphatase. Org. Lett. 8, 549-552 (2006).
9. Le Du, M. H., Millan, J. L.: Structural evidence of functional divergence in human alkaline phosphatases. J. Biol. Chem. 277, 49808-49814 (2002).
10. Zhang, L., Balcerzak, M., Radisson, J., Thouverey, C., Pikula, S., Azzar, G., Buchet, R.: Phosphodiesterase activity of alkaline phosphatase in ATP-initiated Ca(2 +) and phosphate deposition in isolated chicken matrix vesicles. J. Biol. Chem. 280, 37289-37296 (2005).
11. Coburn, S. P., Mahuren, J. D., Jain, M., Zubovic, Y., Wortsman, J.: Alkaline phosphatase (EC 3. 1. 3. 1) in serum is inhibited by physiological concentrations of inorganic phosphate. J. Clin. Endocrinology and Metabolism. 83, 3951-3957 (1998).
12. Mathieu, P., Voisine, P., Pepin, A., Shetty, R., Savard, N., Dagenais, F.: Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J. Heart Valve Dis. 14, 353-357 (2005).
13. Sanchez de Medina, F., Martinez-Augustin, O., Gonzalez, R., Ballester, I., Nieto, A., Galvez, J., Zarzuelo, A.: Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem. Pharmacol. 68, 2317-2326 (2004).
14. Tung, C. B., Tung, C. F., Yang, D. Y., Hu, W. H., Hung, D. Z., Peng, Y. C., Chang, C. S.: Extremely high levels of alkaline phosphatase in adult patients as a manifestation of bacteremia. Hepatogastroenterology 52, 1347-1350 (2005).
15. Holtz, K. M., Stec, B., Kantrowitz, E. R.: A model of the transition state in the alkaline phosphatase reaction. J. Biol. Chem. 274, 8351-8354 (1999).
16. Holtz, K. M., Stec, B., Myers, J. K., Antonelli, S. M., Widlanski, T. S., Kantrowitz, E. R.: Alternate modes of binding in two crystal structures of alkaline phosphatase-inhibitor complexes. Protein Sci. 9, 907-915 (2000).
17. Llinas, P., Stura, E. A., Menez, A., Kiss, Z., Stigbrand, T., Millan, J. L., Le Du, M. H.: Structural studies of human placental alkaline phosphatase in complex with functional ligands. J. Mol. Biol. 350, 441-451 (2005).
18. Almi, M., Arduini, A., Casnati, A., Pochini, A., Ungaro, R.: Chloromethylation of calixarenes and synthesis of new water soluble macrocyclic hosts. Tetrahedron 45, 2177-2182 (1989).
19. Kasyan, O., Swierczynski, D., Drapailo, A., Suwinska, K., Lipkowski, J., Kalchenko, V.: Upper rim substituted thiacalix[4]arenes. Tetrahedron Lett. 44, 7167-7170 (2003).
20. Dixon, M., Webb, E. C.: Enzymes. Longman, London (1982). (in Russian, Mir, Moscow).
21. Morris, G. M., Goodsell, D. S., Huey, R., Olson, A. J.: Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2. 4. J. Comput. Aided Mol. Des. 10, 293-304 (1996).
22. Morris, G. M., Goodsel, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., Olson, A. J.: Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19, 1639-1662 (1998).
23. de Backer, M. M., McSweeney, S., Lindley, P. F., Hough, E.: Ligand-binding and metal-exchange crystallographic studies on shrimp alkaline phosphatase. Acta Crystallogr. D Biol. Crystallogr. 60, 1555-1561 (2004).
24. Stote, R. H., Karplus, M.: Zinc binding in proteins and solution: a simple but accurate nonbonded representation. Proteins 23, 12-31 (1995).
25. Case, D. A., Pearlman, D. A., Caldwell, J. W., et al.: AMBER 7. University of California, San Francisco (2002).
26. Guex, N., Peitsch, M. C.: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723 (1997).
27. Iki, N., Miyano, S.: Can thiacalixarene surpass calixarene? J. Incl. Phenom. Macrocycl. Chem. 41, 99-105 (2001).
28. Grootenhuis, P. D. J., Kollman, P. A., Groenen, L. G., Reinhoudt, D. N., van Hummel, G. J., Ugozzoli, F., Andreetti, G. D.: Computational study of the structural, energetical, and acid-base properties of calix[4]arenes. J. Am. Chem. Soc. 112, 4165-4176 (1990).
29. Groenen, L. G., Steinwender, E., Lutz, B. T. G., van der Maas, J. H., Reinhoudt, D. N.: Solvents effects on the conformations and hydrogen bond structure of partially methylated p-tret-butylcalix[4]arenes. J. Chem. Soc., Perkin Trans. 2, 1893-1898 (1992).
30. Manes, T., Hoylaerts, M. F., Muller, R., Lottspeich, F., Holke, W., Millan, J. L.: Genetic complexity, structure, and characterization of highly active bovine intestinal alkaline phosphatases. J. Biol. Chem. 273, 23353-23360 (1998).
31. Hong, J., Ham, S.: Comparative study of calix[4]arene derivatives: implications for ligand design. Tetrahedron Lett. 49, 2393-2396 (2008).